The Latin America, Middle East and Africa Insomnia Market would witness market growth of 9.8% CAGR during the forecast period (2022-2028).
Numerous physical and mental health conditions and insomnia are related to one another. Consistent sleep deprivation raises the risk for diseases like high blood pressure, heart disease, diabetes, and chronic pain. In addition to prescription medicines, over-the-counter medicines can also cause insomnia. Consulting the doctor for advice on how to treat the condition or medication, as well as the sleep issues, if it has been proven that it causes insomnia is crucial. Without treatment, insomnia is not likely to get better.
Many adults eventually go through short-term or acute insomnia, which can last for days or weeks. Typically, stress or a traumatic event is the cause. However, some people experience chronic long-term sleep disorder that lasts for a month or even longer. The main issue might be insomnia, or it might also be related to other illnesses or medications. To find out the cause of the sleep disorder & how to treat it, consulting a doctor is essential.
The average amount of sleep time for study participants was 5 hours and 24 minutes, which is significantly less than the amount of time suggested by sleep standards. The study's findings also revealed a strong correlation between total sleep time & overall sleep quality with excitement. Future research should concentrate on methods to enhance the quality of sleep and elements that influence the effectiveness of sleep. The insomnia market is expanding in this region due to the rising incidence of insomnia among students.
The Brazil market dominated the LAMEA Insomnia Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $126.4 million by 2028. The Argentina market is exhibiting a CAGR of 10.4% during (2022 - 2028). Additionally, The UAE market would showcase a CAGR of 9.5% during (2022 - 2028).
Based on Distribution Channel, the market is segmented into Hospital, Retail, and Others. Based on Therapy Type, the market is segmented into Pharmacological and Non-Pharmacological.Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Insomnia Market is Predict to reach $5.7 Billion by 2028, at a CAGR of 3.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Currax Pharmaceuticals LLC (Currax Holdings USA LLC), Eisai Co., Ltd., Merck Group, Pfizer, Inc., Vanda Pharmaceuticals, Inc., Cadila Healthcare Ltd. (Zydus Cadila), Sanofi S.A., Viatris, Inc., Takeda Pharmaceutical Company Limited, and Purdue Pharma L.P.
Scope of the Study
Market Segments Covered in the Report:
By Distribution Channel
By Therapy Type
- Pharmacological
- Non-Pharmacological
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
- Eisai Co., Ltd.
- Merck Group
- Pfizer, Inc.
- Vanda Pharmaceuticals, Inc.
- Cadila Healthcare Ltd. (Zydus Cadila)
- Sanofi S.A.
- Viatris, Inc.
- Takeda Pharmaceutical Company Limited
- Purdue Pharma L.P.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Insomnia Market, by Distribution Channel
1.4.2 LAMEA Insomnia Market, by Therapy Type
1.4.3 LAMEA Insomnia Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Insomnia Market
Chapter 4. LAMEA Insomnia Market by Distribution Channel
4.1 LAMEA Hospital Market by Country
4.2 LAMEA Retail Market by Country
4.3 LAMEA Others Market by Country
Chapter 5. LAMEA Insomnia Market by Therapy Type
5.1 LAMEA Pharmacological Market by Country
5.2 LAMEA Non-Pharmacological Market by Country
Chapter 6. LAMEA Insomnia Market by Country
6.1 Brazil Insomnia Market
6.1.1 Brazil Insomnia Market by Distribution Channel
6.1.2 Brazil Insomnia Market by Therapy Type
6.2 Argentina Insomnia Market
6.2.1 Argentina Insomnia Market by Distribution Channel
6.2.2 Argentina Insomnia Market by Therapy Type
6.3 UAE Insomnia Market
6.3.1 UAE Insomnia Market by Distribution Channel
6.3.2 UAE Insomnia Market by Therapy Type
6.4 Saudi Arabia Insomnia Market
6.4.1 Saudi Arabia Insomnia Market by Distribution Channel
6.4.2 Saudi Arabia Insomnia Market by Therapy Type
6.5 South Africa Insomnia Market
6.5.1 South Africa Insomnia Market by Distribution Channel
6.5.2 South Africa Insomnia Market by Therapy Type
6.6 Nigeria Insomnia Market
6.6.1 Nigeria Insomnia Market by Distribution Channel
6.6.2 Nigeria Insomnia Market by Therapy Type
6.7 Rest of LAMEA Insomnia Market
6.7.1 Rest of LAMEA Insomnia Market by Distribution Channel
6.7.2 Rest of LAMEA Insomnia Market by Therapy Type
Chapter 7. Company Profiles
7.1 Eisai Co., Ltd.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.5.2 Approvals and Trails:
7.2 Takeda Pharmaceutical Company Limited
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trails:
7.3 Vanda Pharmaceuticals, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Research & Development Expenses
7.3.4 Recent strategies and developments:
7.3.4.1 Approval and Trails:
7.4 Cadila Healthcare Ltd. (Zydus Cadila)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Product Launches and Product Expansions:
7.5 Sanofi S.A.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Geographical Expansions:
7.6 Merck Group
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 Pfizer, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional & Segmental Analysis
7.7.4 Research & Development Expense
7.8 Viatris, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Acquisition and Mergers:
7.9.2.2 Geographical Expansions:
7.10. Purdue Pharma L.P.
7.10.1 Company Overview
TABLE 1 LAMEA Insomnia Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Insomnia Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 4 LAMEA Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 5 LAMEA Hospital Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Hospital Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Retail Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Retail Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Insomnia Market by Therapy Type, 2018 - 2021, USD Million
TABLE 12 LAMEA Insomnia Market by Therapy Type, 2022 - 2028, USD Million
TABLE 13 LAMEA Pharmacological Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Pharmacological Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Non-Pharmacological Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Non-Pharmacological Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Insomnia Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Insomnia Market by Country, 2022 - 2028, USD Million
TABLE 19 Brazil Insomnia Market, 2018 - 2021, USD Million
TABLE 20 Brazil Insomnia Market, 2022 - 2028, USD Million
TABLE 21 Brazil Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 22 Brazil Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 23 Brazil Insomnia Market by Therapy Type, 2018 - 2021, USD Million
TABLE 24 Brazil Insomnia Market by Therapy Type, 2022 - 2028, USD Million
TABLE 25 Argentina Insomnia Market, 2018 - 2021, USD Million
TABLE 26 Argentina Insomnia Market, 2022 - 2028, USD Million
TABLE 27 Argentina Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 28 Argentina Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 29 Argentina Insomnia Market by Therapy Type, 2018 - 2021, USD Million
TABLE 30 Argentina Insomnia Market by Therapy Type, 2022 - 2028, USD Million
TABLE 31 UAE Insomnia Market, 2018 - 2021, USD Million
TABLE 32 UAE Insomnia Market, 2022 - 2028, USD Million
TABLE 33 UAE Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 34 UAE Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 35 UAE Insomnia Market by Therapy Type, 2018 - 2021, USD Million
TABLE 36 UAE Insomnia Market by Therapy Type, 2022 - 2028, USD Million
TABLE 37 Saudi Arabia Insomnia Market, 2018 - 2021, USD Million
TABLE 38 Saudi Arabia Insomnia Market, 2022 - 2028, USD Million
TABLE 39 Saudi Arabia Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 40 Saudi Arabia Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 41 Saudi Arabia Insomnia Market by Therapy Type, 2018 - 2021, USD Million
TABLE 42 Saudi Arabia Insomnia Market by Therapy Type, 2022 - 2028, USD Million
TABLE 43 South Africa Insomnia Market, 2018 - 2021, USD Million
TABLE 44 South Africa Insomnia Market, 2022 - 2028, USD Million
TABLE 45 South Africa Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 46 South Africa Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 47 South Africa Insomnia Market by Therapy Type, 2018 - 2021, USD Million
TABLE 48 South Africa Insomnia Market by Therapy Type, 2022 - 2028, USD Million
TABLE 49 Nigeria Insomnia Market, 2018 - 2021, USD Million
TABLE 50 Nigeria Insomnia Market, 2022 - 2028, USD Million
TABLE 51 Nigeria Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 52 Nigeria Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 53 Nigeria Insomnia Market by Therapy Type, 2018 - 2021, USD Million
TABLE 54 Nigeria Insomnia Market by Therapy Type, 2022 - 2028, USD Million
TABLE 55 Rest of LAMEA Insomnia Market, 2018 - 2021, USD Million
TABLE 56 Rest of LAMEA Insomnia Market, 2022 - 2028, USD Million
TABLE 57 Rest of LAMEA Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 58 Rest of LAMEA Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 59 Rest of LAMEA Insomnia Market by Therapy Type, 2018 - 2021, USD Million
TABLE 60 Rest of LAMEA Insomnia Market by Therapy Type, 2022 - 2028, USD Million
TABLE 61 Key Information – Eisai Co., Ltd.
TABLE 62 Key Information – Takeda Pharmaceutical Company Limited
TABLE 63 Key Information – Vanda Pharmaceuticals, Inc.
TABLE 64 Key Information – Cadila Healthcare Ltd.
TABLE 65 Key Information – Sanofi S.A.
TABLE 66 key Information – Merck GrouP
TABLE 67 Key Information – Pfizer, Inc.
TABLE 68 key information – Viatris, Inc.
TABLE 69 Key Information – Currax Pharmaceuticals LLC
TABLE 70 Key Information – Purdue Pharma L.P.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Eisai Co., Ltd.
FIG 3 Recent strategies and developments: Currax Pharmaceuticals LLC